Healthcare -
Biotechnology - NASDAQ - US
$ 1.605
-6.14 %
$ 14.8 M
Market Cap
-0.25
P/E
SABS - CAPITAL EXPENDITURES
Capital Expenditures SABS - SAB Biotherapeutics, Inc.
-197 K
LAST VALUE
86.58%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR